Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments: Observational Cacophony, Randomized Harmony

JAMA. 2020 Aug 18;324(7):625-626. doi: 10.1001/jama.2020.13319.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / therapy*
  • Clinical Studies as Topic / legislation & jurisprudence
  • Humans
  • Observational Studies as Topic*
  • Pragmatic Clinical Trials as Topic
  • Randomized Controlled Trials as Topic*
  • Registries
  • United States